Free Trial

Petros Pharmaceuticals (PTPI) SEC Filings & 10K Form

Petros Pharmaceuticals logo
$0.32 +0.02 (+6.63%)
As of 01/21/2025 04:00 PM Eastern

Recent Petros Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/16/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
3:57 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:21 PM
Petros Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:11 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
10:14 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
10/25/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form DEF 14A
10/25/2024
4:02 PM
Petros Pharmaceuticals (Filer)
Form ARS
10/18/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:07 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:19 PM
Petros Pharmaceuticals (Filer)
Form PRE 14A
10/04/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
05/15/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/01/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM
Ayrton Capital LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G
02/06/2024
9:23 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTPI) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners